COVID-19 Clinical Trials in Philadelphia

Showing 121-140 of 172 trials

Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19)

NCT04480424

The purpose of the study is to determine if a high dose of Intravenous Immune Globulin (IVIG) plus Standard Medical Treatment (SMT) can reduce all-cause mortality versus SMT alone in hospitalized participants with COVID-19 requiring admission to the ICU through Day 29.

COVID-19

Grifols Therapeutics LLC100 participantsStarted Sep 2020

Chandler, Arizona, United States • Coronado, California, United States • Chicago, Illinois, United States +15 more locations

COMPLETEDPhase 2< 1 mile

A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia

NCT04363736

This study will assess the pharmacodynamics, pharmacokinetics, safety and efficacy of two different doses of tocilizumab (TCZ) in combination with standard-of-care (SOC) in hospitalized adult participants with moderate to severe COVID-19 pneumonia.

COVID-19 Pneumonia

Hoffmann-La Roche97 participantsStarted May 2020

Phoenix, Arizona, United States • Fullerton, California, United States • Los Angeles, California, United States +21 more locations

Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19)

A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia

COVID-19 Trials in Other Cities

A Study of Immune Responses to the Virus That Causes COVID-19

Point-of-care Lung Ultrasound (POCUS)-Integrated Study of Admitted Patients With COVID-19

COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients With Pneumonia Caused by SARS-CoV-2.

COVID-19 Vaccines Safety Tracking (CoVaST)

Lymphatic Osteopathic Manipulative Medicine to Enhance Coronavirus (COVID-19) Vaccination Efficacy

A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants

InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-I )

Dapagliflozin in Respiratory Failure in Patients With COVID-19

A Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19

Low-Level Laser Therapy Treatment of Lung Inflammation in Post-COVID-19 Recovery

Convalescent Plasma to Stem Coronavirus (CSSC-001)

Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)

Treatment for COVID-19 in High-Risk Adult Outpatients

Sotrovimab Expanded Access Treatment Protocol (COVID-19)

Study to Evaluate the Effects of AT-527 in Non-Hospitalized Adult Patients With Mild or Moderate COVID-19

Fluvoxamine for Early Treatment of Covid-19 (Stop Covid 2)

Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients

Prone Positioning Short-term Effects on Tissue Oxygen Saturation in Critical COVID-19 Patients

Other Conditions in Philadelphia